Platelet-derived growth factor as an antidepressant treatment selection biomarker: Higher levels selectively predict better outcomes with bupropion-SSRI combination

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Platelet-derived growth factor as an antidepressant treatment selection biomarker: Higher levels selectively predict better outcomes with bupropion-SSRI combination'. Together they form a unique fingerprint.

Medicine & Life Sciences